Single centre experience on the use of low dose subcutaneous cytarabine in treatment of patients with high-risk myelodysplastic syndrome and acute myeloid leukaemia

被引：0
|
作者：
Schneider, T. [1 ]
Narayanan, S. [1 ]
机构：
[1] Univ Hosp Southampton NHS Fdn Trust, Dept Haematol, Southampton, Hants, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 157卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
161
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [31] A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment
    Burnett, Alan K.
    Milligan, Donald
    Prentice, Archie G.
    Goldstone, Anthony H.
    McMullin, Mary F.
    Hills, Robert K.
    Wheatley, Keith
    CANCER, 2007, 109 (06) : 1114 - 1124
  • [32] Intensive treatment in patients with high-risk myelodysplastic syndromes and secondary acute leukaemia
    Bargay, J
    Brunet, S
    Esteve, J
    Ribera, J
    Ribera, J
    Llorente, A
    Marti, J
    Sarrà, J
    Guardia, R
    Pedro, C
    Nomdedeu, B
    Sierra, J
    Besalduch, J
    BONE MARROW TRANSPLANTATION, 2004, 33 : S256 - S256
  • [33] Effect of invasive aspergillosis on risk for different causes of death in older patients with acute myeloid leukaemia or high-risk myelodysplastic syndrome
    Rebecca van Grootveld
    Valentina Masarotto
    Peter A. von dem Borne
    Nicole M. A. Blijlevens
    Dana A. Chitu
    Martha T. van der Beek
    Marta Fiocco
    Mark G. J. de Boer
    BMC Infectious Diseases, 23
  • [34] Effect of invasive aspergillosis on risk for different causes of death in older patients with acute myeloid leukaemia or high-risk myelodysplastic syndrome
    van Grootveld, Rebecca
    Masarotto, Valentina
    von dem Borne, Peter A.
    Blijlevens, Nicole M. A.
    Chitu, Dana A.
    van der Beek, Martha T.
    Fiocco, Marta
    de Boer, Mark G. J.
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [35] LENALIDOMIDE IN LOW RISK MYELODYSPLASTIC SYNDROME: SINGLE CENTRE EXPERIENCE
    Gupta, N.
    Kapoor, R.
    Mahapatra, M.
    Pati, H.
    Mishra, P.
    Seth, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 564 - 564
  • [36] Low dose cytosine arabinoside and all-trans retinoic acid for the treatment of secondary acute myeloid leukaemia and high risk myelodysplastic syndrome
    Venditti, A
    Tamburini, A
    Buccisano, F
    Del Poeta, G
    Aronica, G
    Bruno, A
    Maurillo, L
    Masi, M
    Amadori, S
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 344 - 344
  • [37] Low-Dose Cytarabine versus Best Supportive Care for Patients with Acute Myeloid Leukaemia Unfit for the Standard of Care: Egyptian Centre Experience
    Mohammed, Amrallah A.
    Elsayed, Fifi Mostafa
    MIDDLE EAST JOURNAL OF CANCER, 2021, 12 (03) : 415 - 421
  • [38] Safety and feasibility of home delivery of low dose cytarabine by continuous subcutaneous infusion in acute myeloid leukaemia
    Chakrabartty, J.
    Noble, Y.
    Evans, M.
    Ward, S. M.
    Mangi, M.
    Bowcock, S. J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 : 65 - 66
  • [39] Bone marrow mononuclear cell telomere length in acute myeloid leukaemia and high-risk myelodysplastic syndrome
    Warny, Marie
    Helby, Jens
    Sengelov, Henrik
    Nordestgaard, Borge G.
    Birgens, Henrik
    Bojesen, Stig E.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (03) : 218 - 226
  • [40] A Real-life Turkish Experience of Venetoclax Treatment in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia
    Gemici, Aliihsan
    Ozkalemkas, Fahir
    Dogu, Mehmet Hilmi
    Tekinalp, Atakan
    Alacacioglu, Inci
    Guney, Tekin
    Ince, Idris
    Geduk, Ayfer
    Cagliyan, Gulsum Akgun
    Maral, Senem
    Serin, Istemi
    Gunduz, Eren
    Karakus, Volkan
    Bekoz, Huseyin Saffet
    Eren, Rafet
    Pinar, Ibrahim Ethem
    Gunes, Ahmet Kursad
    Sargin, Fatma Deniz
    Sevindik, Omur Gokmen
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (08): : E686 - E692
12345